Inventor · disambiguated record
Ronald K. Blackman
Also filed as: BLACKMAN RONALD K
2 granted patents·12 pending applications·7 citations·filing 2001–2015
54Inventor score
Top patents by PatentIndex Score
14 records- 0181US8815945B2Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancersNAGAI MASAZUMI·Filed 2011·Granted Aug 26, 2014·4 cites·16 claims
- 0275US9205086B2Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitorBLACKMAN RONALD K·Filed 2011·Granted Dec 8, 2015·3 cites·3 claims
- 0349US2016120849A1Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitorSYNTA PHARMACEUTICALS CORP·Filed 2015·Application pending·0 cites
- 0446US2014113972A1Preselection of subjects for therapeutic treatment with elesclomol based on hypoxic statusBLACKMAN RONALD K·Filed 2013·Application pending·0 cites
- 0541US2002037495A1High throughput screening for inhibitors of fatty acid, ergosterol, sphingolipid, or phospholipid synthesis in fungiFiled 2001·Application pending·0 cites
- 0640US2012128580A1Preselection of subjects for therapeutic treatment with elesclomol based on hypoxic statusBLACKMAN RONALD K·Filed 2011·Application pending·0 cites
- 0739US2012128665A1Preselection of subjects for therapeutic treatment based on hypoxic statusBLACKMAN RONALD K·Filed 2011·Application pending·0 cites
- 0839US2014178366A1Preselection of subjects for therapeutic treatment based on hypoxic statusBLACKMAN RONALD K·Filed 2013·Application pending·0 cites
- 0936US2002072051A1Screen for identifying inhibitors of GPI anchoringFiled 2001·Application pending·0 cites
- 1036US2013156755A1Cancer therapy using a combination of a hsp90 inhibitory compounds and a vegf inhibitorBLACKMAN RONALD K·Filed 2011·Application pending·0 cites
- 1134US2014024030A1Preselection of subjects for therapeutic treatment with oxygen sensitive agents based in hypoxic statusBLACKMAN RONALD K·Filed 2013·Application pending·0 cites
- 1231US2014045908A1Hsp90 inhibitory compounds in treating jak/stat signaling-mediated cancersBLACKMAN RONALD K·Filed 2012·Application pending·0 cites
- 1329US2013171105A1Cancer therapy using a combination of a hsp90 inhibitory compound and a topoisomerase ii inhibitorBLACKMAN RONALD K·Filed 2011·Application pending·0 cites
- 1428US2012245186A1Combination cancer therapy with hsp90 inhibitory compoundsBLACKMAN RONALD K·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ronald K. Blackman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →